Bora Lands $250M Biologics Deal with GSK
February 23, 2026
CDMO Bora signs a $250M biologics manufacturing deal with GSK, expanding its global footprint and giving GSK added external capacity for biologic medicines.
February 23, 2026
CDMO Bora signs a $250M biologics manufacturing deal with GSK, expanding its global footprint and giving GSK added external capacity for biologic medicines.